Cargando…
Destabilization of Lysophosphatidic Acid Receptor 1 Reduces Cytokine Release and Protects Against Lung Injury
Lysophosphatidic acid receptor 1 (LPA1) is a druggable target for treating pulmonary inflammatory diseases. However, the molecular regulation of LPA1 stability, a factor that critically impacts its biological activity, remains largely unknown. Here we identify two enzymes that regulate the balance o...
Autores principales: | Zhao, Jing, Wei, Jianxin, Dong, Su, Bowser, Rachel K., Zhang, Lina, Jacko, Anastasia M., Zhao, Yutong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006730/ https://www.ncbi.nlm.nih.gov/pubmed/27448760 http://dx.doi.org/10.1016/j.ebiom.2016.07.020 |
Ejemplares similares
-
Antibodies Against Lysophosphatidic Acid Protect Against Blast-Induced Ocular Injuries
por: Arun, Peethambaran, et al.
Publicado: (2020) -
Lysophosphatidic acid protects against acetaminophen-induced acute liver injury
por: Bae, Geon Ho, et al.
Publicado: (2017) -
The deubiquitinase USP13 stabilizes the anti-inflammatory receptor IL-1R8/Sigirr to suppress lung inflammation
por: Li, Lian, et al.
Publicado: (2019) -
L-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin
por: Clair, Timothy, et al.
Publicado: (2005) -
BGP-15 Protects against Oxidative Stress- or Lipopolysaccharide-Induced Mitochondrial Destabilization and Reduces Mitochondrial Production of Reactive Oxygen Species
por: Sumegi, Katalin, et al.
Publicado: (2017)